Forbes

A public health expert breaks down the the most important public health issues facing Americans for the March 2026 CDC Vaccine Advisory Committee meeting

CVS Health and Google have partnered to use artificial intelligence to increase consumer engagement and support better health outcomes.

In this week’s edition of InnovationRx, we look at the startup that wants to treat Alzheimer’s with microrobots, medical groups push back on RFK’s vaccine changes and more.

Trump administration says it wants to tackle the "addiction epidemic." But it's eliminating addiction treatment resources and access to mental healthcare.

Seattle Storm point guard Erica Wheeler talks about losing her mother to cervical cancer and how she is advocating for more women to get screened.

New research on private equity in dentistry shows costs don’t rise through contract prices, but market competition will determine the long-term impact.

A new Stanford/Harvard study assessed 31 AI models. Here's the winner and the full list of AIs ranked by how well they answer complex clinical questions.

The retirement of David Cordani as CEO of The Cigna Group will be the fourth departure of a long-time health insurance executive during a turbulent time for the industry.

It’s important to follow guidance on prostate-specific antigen screening that maximizes benefits and minimizes potential harms such as overdiagnosis and overtreatment.

Centenarians share a distinct, youth‑like blood protein profile in immune, metabolic, and repair pathways, suggesting circulating factors may help sustain exceptional longevity.

This is less than a year after the Teal Wand from Teal Health became the first at-home cervical cancer screening test approved by the U.S. Food and Drug Administration.

For asymptomatic people without known risks, the downsides and uncertainties of multi-cancer early detection testing could outweigh potential benefits.

The Cigna Group's long-time CEO David M. Cordani will retire effective July 1 and be replaced by current president and chief operating officer Brian Evanko.

MMI is starting FDA-approved human trials for its tiny robot to use needles the size of eyelashes to help clear waste from the brains of Alzheimer’s patients.

New study finds that the costs of removing motorcycle helmet laws continue to rise for both hospitals and taxpayers.